However, another study by Meng et al. found out that both the CD133+ and CD133- subpopulations from SCLC cells contain similar numbers of cancer stem cells, which suggest that CD133 alone cannot be used as a stem cell marker for the SCLC [7]. This evidence concerns the gene PROM1 and cancer.